UPSA

Franceupsa.com

Its role Offtaker

project tracked
1
news articles
2
French pharmaceutical company founded in 1935, specializing in OTC medicines, medical devices and dietary supplements. Leading French manufacturer of paracetamol-based products with main production site in Agen. Partner with SEQENS (and Sanofi/Opella) for reshoring paracetamol API production in France.

Also known as Union de Pharmacologie Scientifique Appliquée.

Projects UPSA is involved in

chemXplore tracks 1 project involving UPSA, of which one is active.

  1. none Announced / Concept
  2. none FEED / Pre-FID
  3. none FID / Sanctioned
  4. 1 project Under Construction
  5. none Commissioning & Start-up

1 more active project is in the record. See all 1 in chemXplore →

What its projects make

UPSA in chemical industry news

15 December 2025
SEQENS advances paracetamol production unit at Roussillon

Continuous-flow, lower-footprint paracetamol process; 15,000 t/yr from end‑2026; backed by France 2030 with UPSA and Opella as partners.

29 July 2021
SEQENS to Build New Paracetamol Unit in Roussillon, France

The new unit, supported by France Relance, will produce 10,000 tonnes of paracetamol annually by 2023, using innovative, eco-friendly processes to meet growing demand and enhance EU health sovereignty.

Where its projects are

active all projects

  • France 1 active project, 1 in all
chemXplore Cluster Watch · updated daily
The 16 chemical clusters of Northwest Europe, read as one system
Hydrogen CO2 Oil, gas and chemicals Heat and power
Open the map →